| Endogenous cannabinoid system regulates intestinal barrier function in vivo through cannabinoid type 1 receptor activation. Zoppi S., Madrigal J.L., Perez-Nievas B.G., Marin-Jimenez I., Caso J.R., Alou L., Garcia-Bueno B., Colon A., Manzanares J., Gomez-Lus M.L. et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 302:G565-71(2012) · Mapped (2) |
| Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors. Garcia-Gutierrez M.S., Garcia-Bueno B., Zoppi S., Leza J.C., Manzanares J.
Br. J. Pharmacol. 165:951-964(2012) · Mapped (1) |
| Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Zoppi S., Perez Nievas B.G., Madrigal J.L., Manzanares J., Leza J.C., Garcia-Bueno B.
Neuropsychopharmacology 36:805-818(2011) · Mapped (2) |
| Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex. Marcelli M., Zoppi S., Wilson C.M., Griffin J.E., McPhaul M.J.
J. Clin. Invest. 94:1642-1650(1994) · UniProtKB (1) |
| A mutation in the DNA-binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor-positive androgen resistance. Marcelli M., Zoppi S., Grino P.B., Griffin J.E., Wilson J.D., McPhaul M.J.
J. Clin. Invest. 87:1123-1126(1991) · UniProtKB (1) |
| Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (Arg-->Cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function. Marcelli M., Tilley W.D., Zoppi S., Griffin J.E., Wilson J.D., McPhaul M.J.
J. Clin. Endocrinol. Metab. 73:318-325(1991) · UniProtKB (1) |
| Immunoreactive androgen receptor expression in subjects with androgen resistance. Wilson C.M., Griffin J.E., Wilson J.D., Marcelli M., Zoppi S., McPhaul M.J.
J. Clin. Endocrinol. Metab. 75:1474-1478(1992) · UniProtKB (1) |
| Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene. McPhaul M.J., Marcelli M., Zoppi S., Wilson C.M., Griffin J.E., Wilson J.D.
J. Clin. Invest. 90:2097-2101(1992) · UniProtKB (1) |
| Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance. Zoppi S., Marcelli M., Deslypere J.-P., Griffin J.E., Wilson J.D., McPhaul M.J.
Mol. Endocrinol. 6:409-415(1992) · UniProtKB (1) |
